Reactions 1680, p112 - 2 Dec 2017 Hepatitis: case report In a study consisting of 44 patients, a patient [age and sex not stated] was described who developed hepatitis [duration of treatment to reaction onset and reaction outcome not stated] following treatment with dapsone [route, dosage and indication not stated]. The patient also had a skin injury and died because of multi-organ failure. Author comment: "We identified 44 cases of [dapsone- induced hepatitis] among 850 patients". Devarbhavi H, et al. Features and Treatment of Dapsone-Induced Hepatitis, Based on Analysis of 44 cases and Literature Review. Clinical Gastroenterology and Hepatology 15: 1805-1807, No. 11, Nov 2017. Available from: URL: http:// doi.org/10.1016/j.cgh.2017.05.031 - India 803284985 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera